125 related articles for article (PubMed ID: 17961876)
21. Immunogenicity and reactogenicity of DTPa-IPV/Hib vaccine co-administered with hepatitis B vaccine for primary and booster vaccination of Taiwanese infants.
Shao PL; Lu CY; Hsieh YC; Bock HL; Huang LM;
J Formos Med Assoc; 2011 Jun; 110(6):415-22. PubMed ID: 21741011
[TBL] [Abstract][Full Text] [Related]
22. Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine.
Faingezicht I; Avila-Aguerro ML; Cervantes Y; Fourneau M; Clemens SA
Rev Panam Salud Publica; 2002 Oct; 12(4):247-57. PubMed ID: 12431356
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity, Safety and Reactogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable H. influenzae Protein D Conjugate Vaccine Coadministered With DTPa-IPV-Hib in Dutch Children: A Randomized Controlled Trial.
van den Bergh MR; Spijkerman J; François N; Swinnen K; Borys D; Schuerman L; Veenhoven RH; Sanders EA
Pediatr Infect Dis J; 2016 Jul; 35(7):e206-19. PubMed ID: 27097348
[TBL] [Abstract][Full Text] [Related]
24. A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw-HBV-Hib, a liquid pentavalent vaccine in Indian infants.
Sharma H; Yadav S; Lalwani S; Gupta V; Kapre S; Jadhav S; Chakravarty A; Parekh S; Palkar S
Vaccine; 2011 Mar; 29(13):2359-64. PubMed ID: 21288803
[TBL] [Abstract][Full Text] [Related]
25. A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity.
Nolan T; Hogg G; Darcy MA; Skeljo M; Carlin J; Boslego J
Vaccine; 2001 Feb; 19(15-16):2127-37. PubMed ID: 11228385
[TBL] [Abstract][Full Text] [Related]
26. Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine.
Nolan T; Altmann A; Skeljo M; Streeton C; Schuerman L
Vaccine; 2004 Nov; 23(1):14-20. PubMed ID: 15519702
[TBL] [Abstract][Full Text] [Related]
27. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A
J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252
[TBL] [Abstract][Full Text] [Related]
28. DTPw-HB and Hib primary and booster vaccination: combined versus separate administration to Latin American children.
Santos JI; Martin A; De Leon T; Rivera L; Gaitán ME; Del Rio C; Oselka G; Cervantes Y; Rubio P; Clemens SA; de Mendonça JS
Vaccine; 2002 Mar; 20(13-14):1887-93. PubMed ID: 11906779
[TBL] [Abstract][Full Text] [Related]
29. A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age.
Szenborn L; Czajka H; Brzostek J; Konior R; Caubet M; Ulianov L; Leyssen M
Pediatr Infect Dis J; 2013 Jul; 32(7):777-85. PubMed ID: 23838777
[TBL] [Abstract][Full Text] [Related]
30. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
[TBL] [Abstract][Full Text] [Related]
31. Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine.
Arístegui J; Usonis V; Coovadia H; Riedemann S; Win KM; Gatchalian S; Bock HL
Int J Infect Dis; 2003 Jun; 7(2):143-51. PubMed ID: 12839717
[TBL] [Abstract][Full Text] [Related]
32. Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/I-Hib vaccines in a post-marketing surveillance setting.
Lim FS; Phua KB; Lee BW; Quak SH; Teoh YL; Ramakrishnan G; Han HH; Van Der Meeren O; Jacquets JM; Bock HL
Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):138-47. PubMed ID: 21323176
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial.
van den Bergh MR; Spijkerman J; François N; Swinnen K; Borys D; Schuerman L; Veenhoven RH; Sanders EA
Pediatr Infect Dis J; 2011 Sep; 30(9):e170-8. PubMed ID: 21487327
[TBL] [Abstract][Full Text] [Related]
35. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
[TBL] [Abstract][Full Text] [Related]
36. A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of age.
Thollot F; Scheifele D; Pankow-Culot H; Cheuvart B; Leyssen M; Ulianov L; Miller JM
Pediatr Infect Dis J; 2014 Dec; 33(12):1246-54. PubMed ID: 25037033
[TBL] [Abstract][Full Text] [Related]
37. The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants.
Prymula R; David MP; Lefevre I; Kohl I; Stefkovicová M
Hum Vaccin; 2007; 3(4):121-6. PubMed ID: 17404515
[TBL] [Abstract][Full Text] [Related]
38. Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants.
Vesikari T; Borrow R; Da Costa X; Richard P; Eymin C; Boisnard F; Lockhart S
Vaccine; 2017 Jan; 35(3):452-458. PubMed ID: 27939054
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine.
Gimenez-Sanchez F; Kieninger DM; Kueper K; Martinon-Torres F; Bernaola E; Diez-Domingo J; Steul K; Juergens C; Gurtman A; Giardina P; Liang JZ; Gruber WC; Emini EA; Scott DA;
Vaccine; 2011 Aug; 29(35):6042-8. PubMed ID: 21704105
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule.
Avdicová M; Prikazský V; Hudecková H; Schuerman L; Willems P
Eur J Pediatr; 2002 Nov; 161(11):581-7. PubMed ID: 12424582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]